Literature DB >> 15753131

Inter- and intra-individual vitamin E uptake in healthy subjects is highly repeatable across a wide supplementation dose range.

Frank J Kelly1, Rosalind Lee, Ian S Mudway.   

Abstract

Vitamin E uptake after supplementation varies widely in the healthy population, and preliminary studies have indicated that individual responses are relatively stable over periods in excess of 1 year. This phenotypic stability suggests a genetic basis to this observed variation. To examine this issue further, we examined the repeatability of both baseline plasma alpha-tocopherol and urinary alpha-tocopherol metabolite concentrations, as well as individual responses of these parameters after vitamin E supplementation. In the first study, 65 subjects (33 males, 32 females, aged 30.7 +/- 7.4 years) provided three plasma and urine samples for alpha-tocopherol and metabolite analysis with each collection separated by at least 2 weeks. Plasma alpha-tocopherol concentrations were found to be highly repeatable over this short interval (intra-class correlation coefficient [ICC] = 0.85), although the association deteriorated once values were corrected for plasma cholesterol (ICC = 0.64). Similarly, urinary alpha-tocopherol metabolites 2(2'-carboxyethyl)-6-hydroxychroman acid (alpha-CEHC) and quinone lactone (QL) concentration were found to display a moderate degree of intra-subject repeatability: ICC = 0.65 and 0.58, respectively. In a second study, plasma alpha-tocopherol and urinary metabolite responses were investigated in 18 healthy, nonsmoking subjects (12 males, 6 females, aged 33.1 +/- 9.1 years) after successive 6-week periods of vitamin E (RRR-alpha-tocopherol acetate) supplementation at 15, 100, 200, and 400 mg/day. Plasma and urine samples were obtained on days 0, 7, 14, 21, and 28 (7 days after the final supplement) of each dosing period and the strength of the underlying association between responses determined using Kendall's tau_b test. Individual plasma alpha-tocopherol responses at the 100, 200, and 400 mg/day doses were found to be highly associated: tau, 0.51, P = 0.02 [100 vs. 200] and tau, 0.49, P = 0.03 [100 vs. 400] and tau, 0.56, P = 0.005 [200 vs. 400]. Together these data support the contention that alpha-tocopherol uptake is a stable individual phenotype under genetic regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15753131     DOI: 10.1196/annals.1331.003

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity.

Authors:  Sabrina A Bardowell; David E Stec; Robert S Parker
Journal:  J Nutr       Date:  2010-09-22       Impact factor: 4.798

2.  Tocopherol transfer protein sensitizes prostate cancer cells to vitamin E.

Authors:  Samantha Morley; Varsha Thakur; David Danielpour; Robert Parker; Hiroyuki Arai; Jeffrey Atkinson; Jill Barnholtz-Sloan; Eric Klein; Danny Manor
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

3.  Expression of the α-tocopherol transfer protein gene is regulated by oxidative stress and common single-nucleotide polymorphisms.

Authors:  Lynn Ulatowski; Cara Dreussi; Noa Noy; Jill Barnholtz-Sloan; Eric Klein; Danny Manor
Journal:  Free Radic Biol Med       Date:  2012-10-16       Impact factor: 7.376

4.  Evidence of different metabolic phenotypes in humans.

Authors:  Michael Assfalg; Ivano Bertini; Donato Colangiuli; Claudio Luchinat; Hartmut Schäfer; Birk Schütz; Manfred Spraul
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

Review 5.  Vitamin E Metabolic Effects and Genetic Variants: A Challenge for Precision Nutrition in Obesity and Associated Disturbances.

Authors:  Sebastià Galmés; Francisca Serra; Andreu Palou
Journal:  Nutrients       Date:  2018-12-04       Impact factor: 5.717

6.  Alpha-Tocopherol Metabolites (the Vitamin E Metabolome) and Their Interindividual Variability during Supplementation.

Authors:  Desirée Bartolini; Rita Marinelli; Danilo Giusepponi; Roberta Galarini; Carolina Barola; Anna Maria Stabile; Bartolomeo Sebastiani; Fabiola Paoletti; Michele Betti; Mario Rende; Francesco Galli
Journal:  Antioxidants (Basel)       Date:  2021-01-25

7.  Upregulation of pERK and c-JUN by γ-tocotrienol and not α-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells.

Authors:  Christine Moore; Victoria E Palau; Rashid Mahboob; Janet Lightner; William Stone; Koyamangalath Krishnan
Journal:  BMC Cancer       Date:  2020-05-15       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.